Expert Depositions Created A New Threat Of Widespread Dismissals In The Federal Talc Litigation

Expert depositions conducted during May 2026 increased attention on scientific reliability and plaintiff-specific proof

Monday, July 27, 2026 - The federal talc litigation entered an important phase during May 2026 as expert depositions placed renewed attention on the scientific opinions supporting thousands of ovarian cancer lawsuits. Expert depositions allow attorneys to question scientific and medical witnesses under oath before trial, giving both sides an opportunity to examine the methods, data, and reasoning behind their opinions. In complex product liability litigation, these depositions often become some of the most closely analyzed parts of the discovery process because judges may later rely on that testimony when deciding whether certain expert opinions should be presented to a jury. As questioning continued throughout May, increasing attention was directed toward whether individual opinions were supported by reliable scientific methods and sufficient plaintiff-specific evidence. If important expert opinions are later limited or excluded, some lawsuits may face greater difficulty continuing through the litigation process. Although every case remains unique, the depositions highlighted how critical expert testimony has become in determining which claims are positioned to move forward. Lawyers reviewing talcum powder ovarian cancer lawsuit claims continue evaluating new talcum powder ovarian cancer lawsuits involving women who allege injuries following long-term talcum powder use.

According to the official records of the United States District Court overseeing the federal multidistrict litigation, expert testimony must satisfy established legal standards before it may be admitted during trial. Depositions provide attorneys with an opportunity to examine the qualifications of expert witnesses, the scientific literature they rely upon, the methods they used to reach their conclusions, and how those opinions apply to individual plaintiffs. After reviewing deposition testimony, courts may consider motions challenging whether particular opinions are sufficiently reliable under the applicable rules of evidence. If a judge determines that certain testimony should be limited or excluded, the decision can significantly affect the strength of individual lawsuits. In some situations, plaintiffs whose claims depend heavily on excluded expert opinions may encounter additional legal obstacles before their cases can proceed. That possibility has increased attention on the May 2026 depositions because they created a detailed record that may influence future evidentiary rulings throughout the litigation. While no single deposition determines the outcome of every lawsuit, the testimony collected during discovery often becomes an important foundation for later court decisions.

The May 2026 expert depositions may prove to be one of the most influential stages of the federal talc litigation because they highlighted the central role scientific testimony plays in thousands of pending ovarian cancer lawsuits. If future court rulings conclude that certain expert opinions fail to satisfy legal standards, some plaintiffs could face motions seeking dismissal before trial. At the same time, expert opinions that withstand judicial review may strengthen the position of other cases moving toward bellwether proceedings or settlement discussions. The depositions themselves did not dismiss any claims, but they created an extensive factual record that judges may rely upon when evaluating future evidentiary disputes. As the federal litigation continues to evolve, the quality, reliability, and plaintiff-specific application of expert testimony are likely to remain among the most important factors affecting how individual lawsuits proceed. For that reason, the May 2026 depositions have become a significant development that could influence whether large numbers of federal talc claims continue forward or face increasing procedural challenges.